How to Buy Regeneron Pharmaceuticals Stock
Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
Regeneron Pharmaceuticals stock last closed at $780.86, down 0.29% from the previous day, and has increased 25.47% in one year. It has overperformed other stocks in the Biotechnology industry by 0.41 percentage points. Regeneron Pharmaceuticals stock is currently +45.14% from its 52-week low of $538.01, and -2.45% from its 52-week high of $800.48.
There are currently 109.33M shares of REGN outstanding. The market capitalization of REGN is $85.37B. In the last 24 hours, 1.06M REGN shares were traded.
How to Buy Regeneron Pharmaceuticals Stock
Not sure how to invest in Regeneron Pharmaceuticals stock? Here's how.
- Figure out where to buy Regeneron Pharmaceuticals stock: You need to choose a stock brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you choose where to buy Regeneron Pharmaceuticals stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit funds into your brokerage account: Pick your payment method and add your info.
- Research Regeneron Pharmaceuticals stock: The Regeneron Pharmaceuticals ticker symbol is REGN. Is Regeneron Pharmaceuticals stock a good investment? Should you buy shares of REGN? How do REGN's underlying business fundamentals look? Do top analysts think Regeneron Pharmaceuticals is a good buy? Why has REGN's stock price moved recently? (Hint: Our stock research tools can help you understand if REGN is a good stock to buy).
- Make your REGN buy order: Decide if you will purchase REGN shares at the current market price or use a limit order to purchase REGN shares at a particular price.
- Get key alerts regarding your REGN investment: Create a watchlist to keep tabs on your new investment in Regeneron Pharmaceuticals stock.
Step 1: Figure out where to buy Regeneron Pharmaceuticals stock
You need an online brokerage account in order to access the NASDAQ market and buy REGN stock.
Our recommended brokerage: eToro
We believe that eToro is the best stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world markets: From Technology to Industrials, New York to London — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by creating an account with eToro today.
Open eToro AccountStep 2: Create your brokerage account
Now that you've chosen the right brokerage, you need to fill out some personal details so you can invest in REGN stock today.
How to Start a New Account on eToro
- Click here to get started.
- Input your personal details to open a new brokerage account.
- Submit your application by clicking the "Create Account" button.
Step 3: Deposit funds into your brokerage account
Now that you've opened your account on the best free stock trading app, you need to deposit funds:
Watch the tutorial below to see the process of transferring funds into your new investment account.
Step 4: Research Regeneron Pharmaceuticals stock
After you have figured out the best place to buy Regeneron Pharmaceuticals stock, it's very important to evaluate their stock prior to buying, so you can comprehend the risk and upside.
Regeneron Pharmaceuticals stock quick numbers
REGN Due Diligence Checks
WallStreetZen was created to help average investors do better fundamental analysis.
You can see all of the due diligence checks on REGN's stock page.
Is REGN stock properly valued?
You can use many financial metrics, analyses, models, and charts to gauge REGN's fair value.
Using relative valuations metrics:
- REGN could be overvalued based on its P/E ratio of 19.28x, relative to Biotechnology industry P/E ratio of 11.5x
- REGN could be undervalued based on its P/B ratio of 3.77x, relative to Biotechnology industry P/B ratio of 5.06x
- REGN could be overvalued based on its PEG ratio of 16.95x
You can do additional valuation research on REGN's stock here.
A look at REGN Cashflows and Balance Sheet
Positive Health Checks:
- REGN earnings of $4.92B is not sufficient to cover its interest payments.
- REGN's operating cash flow of $5.01B allows it to safely service it's debt of $2.70B.
- There are more short-term assets than short-term liabilities on the REGN balance sheet.
- Total REGN debt is lower than 5 years ago, relative to shareholder equity.
- REGN has a low debt to equity ratio of 0.29.
- There are more short-term assets than long-term liabilities on the REGN balance sheet.
Negative Health Checks:
- REGN profit margin has gone down from 50.2% to 35.6% in the past year.
Do Wall Street analysts think it's a good time to buy REGN stock
Out of 20 sell side analysts who give ratings on REGN, the consensus analyst rating on Regeneron Pharmaceuticals is a Buy
Please note that analyst forecasts are not stock recommendations, nor are they investment advice.
Most Recent REGN Analyst Upgrades/Downgrades
Brian Abrahams, a top 2% analyst from RBC Capital maintains REGN with a hold rating and lowers their REGN price target from $789.00 to $787.00, on Feb 6, 2023.
Brian Skorney, a top 14% analyst from Baird maintains REGN with a hold rating and raises their REGN price target from $670.00 to $756.00, on Feb 6, 2023.
Matthew Harrison, a bottom 6% analyst from Morgan Stanley maintains REGN with a strong buy rating and raises their REGN price target from $873.00 to $883.00, on Feb 6, 2023.
David Risinger, a top 9% analyst from SVB Leerink maintains REGN with a hold rating and raises their REGN price target from $770.00 to $834.00, on Feb 6, 2023.
Tyler Van Buren, a bottom 4% analyst from Cowen & Co. upgrades REGN to a buy rating and raises their REGN price target from $775.00 to $875.00, on Jan 30, 2023.
You can dive deeper into what analysts are saying on the Regeneron Pharmaceuticals stock forecast page.
Metrics for Advanced REGN Traders
How is REGN performing as a company?
Last year, REGN earnings were $4.34B. In the last 5 year, REGN's earnings have grown by 29.16% per year. This was faster than the Biotechnology industry average of 18.5%.
Last year, REGN revenue was $12.17B. Over the past five year, REGN's revenue has increased by 15.7% per year. This was slower than the Biotechnology industry average of 75.62%.
You can research REGN's earnings and revenue performance here.
Who is buying/selling REGN?
In the last year, executives and large shareholders at REGN have sold more shares than they have bought.
Marion McCourt, EVP Commercial of REGN, was the latest REGN insider to sell. They sold $827,409.00 worth of REGN shares on Feb 1, 2023.
Get more info about who owns REGN shares here.
Can I get consistent income from REGN stock?
No, Regeneron Pharmaceuticals doesn't provide an income stream by paying out dividends.
What do other investors have to say about REGN?
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your REGN buy order
You have two main order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are generally the best for newer investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a specific price limit, place a limit order.
Hit the Open Trade button and your broker will execute your order.
If you require additional assistance buying stocks on eToro, click the helpful video below:
Step 6: Get key alerts regarding your REGN investment
Now that you own some REGN stock, you'll want to stay up-to-date on your new company.
Make a watchlist to get notified of the latest news about your REGN stock.
REGN Feed
How to Buy Stock in Regeneron Pharmaceuticals
To summarize, here are the 6 steps you need to take to buy Regeneron Pharmaceuticals stock right now:
- Figure out where to buy Regeneron Pharmaceuticals stock
- Create your brokerage account
- Deposit funds into your brokerage account
- Research Regeneron Pharmaceuticals stock
- Make your REGN buy order
- Get key alerts regarding your REGN investment
If you need a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get notifications regarding your new investment in Regeneron Pharmaceuticals, click below.
Related Articles
FAQ
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.